Literature DB >> 27856724

Variability in antibiotic use across Ontario acute care hospitals.

Charlie Tan1, Marian Vermeulen2, Xuesong Wang2, Rosemary Zvonar3, Gary Garber3, Nick Daneman4,2,5.   

Abstract

BACKGROUND: Antibiotic stewardship is a required organizational practice for Canadian acute care hospitals, yet data are scarce regarding the quantity and composition of antibiotic use across facilities. We sought to examine the variability, and risk-adjusted variability, in antibiotic use across acute care hospitals in Ontario, Canada's most populous province.
METHODS: Antibiotic purchasing data from IMS Health, previously demonstrated to correlate strongly with internal antibiotic dispensing data, were acquired for 129 Ontario hospitals from January to December 2014 and linked to patient day (PD) denominator data from administrative datasets. Hospital variation in DDDs/1000 PDs was determined for overall antibiotic use, class-specific use and six practices of clinical or ecological significance. Multivariable risk adjustment for hospital and patient characteristics was used to compare observed versus expected utilization.
RESULTS: There was 7.4-fold variability in the quantity of antibiotic use across the 129 acute care hospitals, from 253 to 1873 DDDs/1000 PDs. Variation was evident within hospital subtypes, exceeded that explained by hospital and patient characteristics, and included wide variability in proportion of broad-spectrum antibiotics (IQR 36%-48%), proportion of fluoroquinolones among respiratory antibiotics (IQR 40%-62%), proportion of ciprofloxacin among urinary anti-infectives (IQR 44%-60%), proportion of antibiotics with highest risk for Clostridium difficile (IQR 29%-40%), proportion of 'reserved-use' antibiotics (IQR 0.8%-3.5%) and proportion of anti-pseudomonal antibiotics among antibiotics with Gram-negative coverage (IQR 26%-40%).
CONCLUSIONS: There is extensive variability in antibiotic use, and risk-adjusted use, across acute care hospitals. This could motivate, focus and benchmark antibiotic stewardship efforts.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27856724     DOI: 10.1093/jac/dkw454

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Hospital-Level Variability in Broad-Spectrum Antibiotic Use for Children With Acute Leukemia Undergoing Hematopoietic Cell Transplantation.

Authors:  Caitlin W Elgarten; Staci D Arnold; Yimei Li; Yuan-Shung V Huang; Marcie L Riches; Jeffrey S Gerber; Richard Aplenc; Wael Saber; Brian T Fisher
Journal:  Infect Control Hosp Epidemiol       Date:  2018-05-08       Impact factor: 3.254

2.  Microbiome-pathogen interactions drive epidemiological dynamics of antibiotic resistance: A modeling study applied to nosocomial pathogen control.

Authors:  Laura Temime; Lulla Opatowski; David Rm Smith
Journal:  Elife       Date:  2021-09-14       Impact factor: 8.140

3.  Predicting In-Hospital Antibiotic Use in the Medical Department: Derivation and Validation Study.

Authors:  Itamar Poran; Michal Elbaz; Adi Turjeman; Maayan Huberman Samuel; Noa Eliakim-Raz; Jeries Nashashibi; Mical Paul; Leonard Leibovici
Journal:  Antibiotics (Basel)       Date:  2022-06-16

Review 4.  In-Hospital Macro-, Meso-, and Micro-Drivers and Interventions for Antibiotic Use and Resistance: A Rapid Evidence Synthesis of Data from Canada and Other OECD Countries.

Authors:  Rosa Stalteri Mastrangelo; Anisa Hajizadeh; Thomas Piggott; Mark Loeb; Michael Wilson; Luis Enrique Colunga Lozano; Yetiani Roldan; Hussein El-Khechen; Anna Miroshnychenko; Priya Thomas; Holger J Schünemann; Robby Nieuwlaat
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-03-16       Impact factor: 2.585

5.  Antimicrobial use among adult inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program: 2009 to 2016.

Authors:  Wallis Rudnick; Michelle Science; Daniel J G Thirion; Kahina Abdesselam; Kelly B Choi; Linda Pelude; Kanchana Amaratunga; Jeannette L Comeau; Bruce Dalton; Johan Delport; Rita Dhami; Joanne Embree; Yannick Émond; Gerald Evans; Charles Frenette; Susan Fryters; Greg German; Jennifer M Grant; Jennifer Happe; Kevin Katz; Pamela Kibsey; Justin Kosar; Joanne M Langley; Bonita E Lee; Marie-Astrid Lefebvre; Jerome A Leis; Allison McGeer; Heather L Neville; Andrew Simor; Kathryn Slayter; Kathryn N Suh; Alena Tse-Chang; Karl Weiss; John Conly
Journal:  Antimicrob Resist Infect Control       Date:  2020-02-13       Impact factor: 4.887

6.  Development of a Machine Learning Model Using Electronic Health Record Data to Identify Antibiotic Use Among Hospitalized Patients.

Authors:  Rebekah W Moehring; Matthew Phelan; Eric Lofgren; Alicia Nelson; Elizabeth Dodds Ashley; Deverick J Anderson; Benjamin A Goldstein
Journal:  JAMA Netw Open       Date:  2021-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.